Extract from our Nordic M&A Newsletter

Read more about our Nordic M&A Newsletter service including the M&A Portal and Private Equity Portfolio Tracker.
Abacus Medicine to IPO at DKK 1.2-1.3bn valuation in May
May 23, 2019

Abacus Medicine, a Danish-based parallel importer and distributor of prescription drugs across Europe. Abacus expects to raise EUR 79.2m in the IPO. Abacus Medicine reported a LTM turnover of EUR 339.6m and LTM EBITDA of EUR 13.3m by March 2019, which corresponds to an EV/EBITDA multiple of 12-13.3x. Abacus will be listed on Frankfurt Stock Exchange.

ⓘ This story was originally featured in our daily Nordic M&A Newsletter - we publish some of the newsletter content with delay through our M&A Newsletter Library. If you would like more insights on this deal or industry then send us an email at requests@nordicknowledgepartners.com